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Objective: Although obesity is a major risk factor for cardiovascular disease, it is not clear whether obesity
increases the risk of postoperative morbidity and mortality in patients undergoing coronary artery bypass grafting
surgery. Increasing evidence suggests that both obesity and renal insufficiency are associated with increased
systemic inflammation, thrombogenicity, and endothelial dysfunction. Cardiac surgical patients with comorbid
obesity and renal insufficiency might thus be at greater risk for systemic proinflammatory and thrombotic states,
which in turn might increase the risk of adverse perioperative outcomes. We investigated the influence of obesity
on adverse postoperative outcomes after coronary artery bypass grafting surgery in patients with andwithout renal
insufficiency.
Methods: A retrospective cohort study was performed of patients (n ¼ 10,863) undergoing primary coronary
artery bypass grafting surgery with cardiopulmonary bypass between January 1995 and June 2005. Patients
with preoperative renal insufficiency (n ¼ 1385) and patients with preoperative normal renal function (n ¼
9478) were further classified as obese (body mass index, 30 kg/m2) or nonobese (body mass index, 18.5–
29.9 kg/m2). Multivariate, stepwise logistic regression was performed, controlling for demographic factors,
medications, and perioperative risk factors to determine whether obesity is independently associated with an
increased risk of adverse postoperative outcomes after coronary artery bypass grafting surgery in patients with
or without renal insufficiency.
Results:Obese patients with preoperative renal insufficiency had higher rates of postoperative myocardial infarc-
tion (5.9% vs 3.4%) and low cardiac output syndrome (24.5% vs 18.6%) and increased hospital stay (14.9 
13.7 vs 13.2  13.0 days) than nonobese patients with preoperative renal insufficiency (all outcomes, P< .05).
Multivariate analysis revealed that obese patients with preoperative renal insufficiency were independently asso-
ciated with an increased risk of postoperative myocardial infarction (odds ratio, 1.82; 95% confidence interval,
1.07–3.07; P< .05) and low cardiac output syndrome (odds ratio, 1.53; 95% confidence interval, 1.15–2.03;
P<.01) and increased hospital stay (P<.05). In contrast, obese patients with normal preoperative renal function
were independently associated only with an increased risk of postoperative sternal wound infection (odds ratio,
2.55; 95% confidence interval, 1.40–4.67; P< .01) and leg wound infection (odds ratio, 2.27; 95% confidence
interval, 1.71–3.02; P< .01).
Conclusion: Obesity is an independent risk factor for increased cardiovascular morbidity and prolonged hospital
stay in patients with preoperative renal insufficiency undergoing primary coronary artery bypass grafting surgery.Patients with obesity are at greater risk of atherosclerotic car-
diovascular events.1-7 Recent studies suggest that obesity is
associated with increased insulin resistance, endothelial
dysfunction, thrombogenicity, and inflammation, which
can consequently promote accelerated atherosclerosis of
the microvasculature and macrovasculature.8-12 Adipose
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doi:10.1016/j.jtcvs.2009.02.019The Journal of Thoracic and Ctissue acts as an active endocrine and paracrine organ, secret-
ing a large number of adipokines or adipocytokines that
influence metabolic and vascular processes, including leptin,
adiponectin, tumor necrosis factor a, interleukin 6, procoa-
gulant plasminogen activator inhibitor 1, visfatin, adipsin,
angiotensinogen, resistin, and retinol-binding protein
4.12,13 It has been observed that levels of proinflammatory
and procoagulation adipokines and cytokines, including
leptin, P-selectin, visfatin, resistin, retinol-binding protein
4, intercellular adhesion molecule 1, tumor necrosis factor
a, interleukin 6, C-reactive protein, and plasminogen activa-
tor inhibitor 1, are increased in obese patients.8,9,12,14-16
Interestingly, persistent inflammation is highly prevalent
in patients with chronic renal disease and associated with
adverse outcomes.17 Axelsson and colleagues18,19 reported
that circulating adipokine and adipocytokine levels are
markedly increased in chronic kidney disease, likelyardiovascular Surgery c Volume 138, Number 4 873
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BMI ¼ body mass index
CABG ¼ coronary artery bypass graft
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
MI ¼ myocardial infarction
OR ¼ odds ratio
because of decreased renal excretion. Increasing evidence
also suggests that increased inflammation contributes to
worsened postoperative outcomes in patients undergoing
cardiopulmonary bypass (CPB).20 Therefore cardiac surgi-
cal patients with comorbid obesity and renal insufficiency
might be at greater risk for insulin resistance, endothelial
dysfunction, and systemic proinflammatory and thrombotic
states, which in turn might further increase their risk of ad-
verse postoperative outcomes. We investigated the influence
of obesity on adverse postoperative outcomes after primary
coronary artery bypass graft (CABG) surgery with CPB in
patients with and without renal insufficiency.
MATERIALS AND METHODS
Study Design
After obtaining institutional review board approval, a retrospective co-
hort study was performed on all patients (n ¼ 10,863) undergoing primary
CABG surgery with CPB at the Texas Heart Institute, St Luke’s Episcopal
Hospital, Houston, Texas, between January 1995 and June 2005. Obesity
was assessed by using body mass index (BMI), which was calculated as
weight (in kilograms)/height (in meters squared). Patients with preoperative
renal insufficiency (n ¼ 1385) and patients with preoperative normal renal
function (n ¼ 9478) were further classified into 2 groups at the time of sur-
gical intervention by using the World Health Organization definition for
obesity: a BMI of 30 kg/m2 or greater for obese patients and a BMI of
18.5 to 29.9 kg/m2 for nonobese patients.1,21 Underweight patients (BMI,
<18.5 kg/m2) were excluded from the study. Patients were classified as hav-
ing preoperative renal insufficiency based on either preoperative diagnosis
of renal insufficiency or failure made by clinicians or a serum creatinine
level of at least 2.0 mg/dL at the time of the operation. Patients undergoing
concomitant valve or other cardiac surgery (eg, atrial septal defect repair or
ventricular aneurysm resection) were excluded from the study.
Data Collection
Patient demographics, perioperative risk factors, and the incidence of ad-
verse postoperative outcomes were obtained from the Texas Heart Institute
cardiac surgical database.Measured adverse postoperative outcomes included
30-day all-cause mortality, myocardial infarction (MI), cardiac arrhythmias,
ventilator dependence, low cardiac output syndrome, stroke, infection, and
need for mediastinal re-exploration. A diagnosis of MI was made if there
were either new Q waves (Minnesota code 1-1-1 to 1-2-7), new persistent
ST-segment or T-wave changes (Minnesota code 4-1, 4-2, 5-1, 5-2, or 9-2),
an increase in serum troponin I level of greater than 10 ng/mL, or clinical
evidence of acute MI on autopsy.22 A diagnosis of low cardiac output
syndrome was made with documented evidence of postoperative cardiogenic
hypotension or shock requiring vasopressor support, use of an intra-aortic
balloon pump, or both. A diagnosis of stroke was made if there was clinical
evidence or evidence of a new focal or global defect on computed tomo-
graphic analysis, magnetic resonance imaging, or autopsy.874 The Journal of Thoracic and Cardiovascular SuStatistical Analysis
All statistical analyses were performed with SAS statistical software
(SAS Institute, Inc, Cary, NC). Patient preoperative demographics, risk
factors, and preoperative medications were first compared between groups
by means of univariate (c2) analysis. All predictor variables significant at
a 2-tailed nominal P value of less than .15 in the univariate analysis were
then entered into a multivariate logistical model, and stepwise logistic
regression was performed to determine whether obesity in patients with
and without preoperative renal insufficiency was independently associated
with an increased risk of adverse postoperative outcomes after primary
CABG surgery. Only those variables significant at a 2-tailed nominal
P value of less than .05 were retained within the model. Odds ratios
(ORs) and corresponding 95% confidence intervals (CIs) are reported,
with associated P values. A c-statistic was calculated for each outcome to
quantify the discriminatory power of the multivariate regression model.
In an attempt to further control for nonrandomization, propensity scores
were also estimated by using unconditional logistic regression to determine
the predicted probability of inclusion in the obese or nonobese group for
each patient. The 24 variables used for propensity matching are shown in
Tables 1 and 2. Obese (n¼ 3331) and nonobese (n¼ 6147) patients with nor-
mal preoperative renal function were then matched 1-to-1 on these variables,
resulting in successful matching of 3002 patients. Similarly, obese (n¼ 474)
and nonobese (n ¼ 911) patients with preoperative renal insufficiency were
also matched 1-to-1 on these variables, resulting in successful matching of
457 patients. All predictor variables significant at a 2-tailed nominal P value
of less than .15 in the univariate analysis were then entered into a multivariate
logistical model, and stepwise logistic regression was performed to determine
whether obesity in propensity score–matchedpatientswith andwithout preop-
erative renal insufficiencywas independently associatedwith an increased risk
of adverse postoperative outcomes after primary CABG surgery.
RESULTS
Patient demographics and perioperative risk factors in non-
obese and obese patients with and without preoperative renal
insufficiency are presented in Tables 1 and 2, respectively. Of
note, the obese and nonobese groups did not significantly dif-
fer with respect to surgical urgency, history of smoking, prior
MI, unstable angina, ejection fraction of less than 50%,
stroke, or preoperativemedications in patients with or without
preoperative renal insufficiency. As expected, the incidence of
diabetes was significantly increased in obese compared with
nonobese patients (P< .01). Obese patients were also signif-
icantly younger than nonobese patients at the time of the
operation (P<.01). Incidences of hypertension and hyperlip-
idemia were higher in obese patients with or without preoper-
ative renal insufficiency (P < .05). Furthermore, aortic
crossclamp and CPB times were longer in obese patients
with or without preoperative renal insufficiency compared
with times in nonobese patients (P< .05).
The incidence of adverse postoperative outcomes in
patients with normal preoperative renal function is presented
in Table 3. In these patients obesity was independently asso-
ciated only with increased risk of postoperative sternal
wound infection (OR, 2.55; 95% CI, 1.40–4.67; P< .01)
and leg wound infection (OR, 2.27; 95% CI, 1.71–3.02;
P< .01). Obesity was not independently associated with
mortality, MI, arrhythmias, stroke, low cardiac output syn-
drome, prolonged hospital stay, or ventilator dependence.rgery c October 2009
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nal re-exploration in obese patients was significantly de-
creased compared with that seen in nonobese patients
(5.8% vs 4.1%, P< .05).23-25 Interestingly, the incidence
of stroke was significantly less in obese patients than in
nonobese patients (1.9% vs 2.8%, P< .05).
The incidence of adverse postoperative outcomes in pa-
tients with preoperative renal insufficiency is presented in
Table 4. In contrast to patients with normal preoperative
renal function, the incidence of postoperative MI (5.9% vs
3.4%, P< .05) and low cardiac output syndrome (24.5%
vs 18.6%, P< .01), the length of hospital stay (14.9 
13.7 vs 13.1 13.0 days, P<.05), and the incidence of ven-
tilator dependence (11.2% vs 8.0%, P ¼ .052) and sternal
wound infection (2.3% vs 0.8%, P<.05) were significantly
greater in obese patients compared with nonobese patients
with univariate analysis, respectively. Furthermore, multi-
variate analysis revealed that obesity in patients with pre-
operative renal insufficiency undergoing CABG was
independently associated with an increased risk of post-
TABLE 1. Perioperative demographic variables and risk factors in
nonobese and obese patients (n ¼ 9478) without preoperative renal
insufficiency undergoing primary CABG surgery
Patient demographics
BMI<30 kg/m2
(n ¼ 6147)
BMI>30 kg/m2
(n ¼ 3331) P value
Age (y) 64  10.71 60.35  10.12 <.01
Female sex (%) 23 27 <.01
Smoker (%) 50 51 NS
Urgent surgical
intervention (%)
18 17 NS
Diabetes (%) 7 12 <.01
Hypertension (%) 69 81 <.01
Triple-vessel disease (%) 57 55 <.05
Left main disease (%) 24 22 <.01
Prior myocardial
infarction (%)
43 42 NS
Unstable angina (%) 54 54 NS
Ejection fraction<50% (%) 38 36 NS
Valve disease (%) 5 4 NS
Congestive heart
failure (%)
13 17 <.01
Transient ischemic
attack (%)
4 3 NS
Stroke (%) 6 5 NS
Pulmonary disease (%) 23 23 NS
Hyperlipidemia (%) 60 64 <.01
Preoperative IABP (%) 4 4 NS
b-Blocker (%) 45 47 NS
Calcium-channel blocker (%) 25 28 NS
Aspirin (%) 63 63 NS
Antiarrhythmics (%) 4 4 NS
Crossclamp time (min) 38  20 40  21 <.01
Total bypass time (min) 66  30 69  33 <.01
CABG, Coronary artery bypass grafting; BMI, body mass index; IABP, intra-aortic
balloon pump.The Journal of Thoracic and Coperative MI (OR, 1.82; 95% CI, 1.07–3.07; P< .05)
and low cardiac output syndrome (OR, 1.53; 95% CI,
1.15–2.03; P < .01) and increased length of hospital
stay (P< .05). In addition, there was a strong trend to-
ward ventilator dependence (OR, 1.45; 95% CI, 0.98–
2.16; P ¼ .065) and sternal wound infection (OR,
2.30; 95% CI, 0.98–6.87; P ¼ .06) in obese patients
with renal insufficiency. Risk-adjusted ORs and CIs for
adverse postoperative outcomes in obese patients with
preoperative renal insufficiency are presented in Figure 1.
The c-statistic for these outcomes ranged from 0.604 to
0.801. No significant differences between obese and non-
obese patients with preoperative renal insufficiency were
observed with respect to the incidence of 30-day all-
cause mortality, atrial or ventricular arrhythmias, stroke,
sepsis, or leg wound infection or the need for mediastinal
re-exploration (Table 4).
In an attempt to further control for selection bias related to
the choice of therapy, stepwise logistic regression was also
performed on a propensity score–matched cohort of 6004
TABLE 2. Perioperative demographic variables and risk factors in
nonobese and obese patients (n ¼ 1385) with preoperative renal
insufficiency undergoing primary CABG surgery
Patient
demographics
BMI<30 kg/m2
(n ¼ 911)
BMI>30 kg/m2
(n ¼ 474) P value
Age (y) 66  10.3 63  10 <.01
Female sex (%) 23 29 <.05
Smoker (%) 52 52 NS
Urgent surgical
intervention (%)
20 19 NS
Diabetes (%) 14 21 <.01
Hypertension (%) 85 88 <.05
Triple-vessel disease (%) 59 57 NS
Left main disease (%) 27 25 NS
Prior myocardial
infarction (%)
46 48 NS
Unstable angina (%) 51 52 NS
Ejection fraction<50% (%) 45 43 NS
Valve disease (%) 9 7 NS
Congestive heart
failure (%)
32 35 NS
Transient ischemic
attack (%)
5 4 NS
Stroke (%) 11 12 NS
Pulmonary disease (%) 34 36 NS
Hyperlipidemia (%) 58 63 <.05
Preoperative IABP (%) 4 5 NS
b-Blocker (%) 49 50 NS
Calcium-channel blocker (%) 33 33 NS
Aspirin (%) 60 62 NS
Antiarrhythmics (%) 7 5 NS
Crossclamp time (min) 40  20 43  25 <.05
Total bypass time (min) 69  33 76  42 <.01
CABG, Coronary artery bypass grafting; BMI, body mass index; IABP, intra-aortic bal-
loon pump.ardiovascular Surgery c Volume 138, Number 4 875
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surgery
Postoperative outcome
BMI<30 kg/m2
(n ¼ 6147)
BMI>30 kg/m2
(n ¼ 3331) P value OR 95% CI
30-d mortality (%) 2.9 2.7 NS 0.91 0.69–1.20
Ventilator dependence (%) 4.2 4.5 NS 1.16 0.93–1.44
Atrial fibrillation (%) 20.0 19.1 NS 1.01 0.90–1.13
Atrial flutter (%) 6.4 5.9 NS 0.94 0.78–1.13
Ventricular fibrillation (%) 3.5 3.1 NS 0.95 0.74–1.21
Ventricular tachycardia (%) 5.5 6.2 NS 1.13 0.93–1.35
Low cardiac output syndrome (%) 12.1 12.2 NS 1.02 0.88–1.16
Stroke (%) 2.7 2.0 .03 0.73 0.54–0.97
Cardiac arrest (%) 5.0 4.4 NS 0.94 0.76–1.16
Myocardial infarction (%) 3.1 3.4 NS 1.08 0.85–1.37
Mediastinal re-exploration (%) 4.8 3.4 .004 0.72 0.57–0.90
Postoperative IABP (%) 4.4 4.5 NS 1.01 0.81–1.25
Sternal wound infection (%) 0.3 0.8 .002 2.55 1.04–4.67
Leg wound infection (%) 1.6 3.2 .001 2.27 1.71–3.22
Sepsis (%) 1.6 1.7 NS 1.061 0.75–1.49
Hospital stay (d) 10.2  9.1 10.5  8.1 NS
CABG, Coronary artery bypass grafting; BMI, body mass index; OR, odds ratio; CI, confidence interval; NS, not significant; IABP, intra-aortic balloon pump.patients with normal preoperative renal function and 904 pa-
tients with preoperative renal insufficiency, respectively.
Even after controlling for propensity score, obesity still inde-
pendently predicted an increased risk of postoperative venti-
lator dependence (P<.05) and low cardiac output syndrome
(P< .01) in patients with preoperative renal insufficiency.
Although the incidence of postoperative MI was not found
to be significantly higher in obese patients with preoperative
renal insufficiency compared with that seen in nonobese
patients, there was a strong trend to suggest that obesity
was associated with increased risk of postoperative MI876 The Journal of Thoracic and Cardiovascular Sur(6.1% vs 3.7%, P ¼ .059) after CABG surgery. The slight
loss in statistical significance in postoperative MI with
propensity analysis is most likely attributable to the loss of
statistical power associated with the 35% reduction in the
total original sample size after propensity matching. Further-
more, no significant differences were observed between
obese and nonobese patients with preoperative renal insuffi-
ciency with respect to the incidence of 30-day all-cause mor-
tality, atrial or ventricular arrhythmias, stroke, sepsis, or leg
wound infection or the need for mediastinal re-exploration.
Similar to the above non–propensity score–matchedTABLE 4. Postoperative outcomes in nonobese and obese patients (n ¼ 1358) with preoperative renal insufficiency undergoing primary CABG
surgery
Postoperative outcome
BMI<30 kg/m2
(n ¼ 911)
BMI>30 kg/m2
(n ¼ 474) P value OR 95% CI
30-d mortality (%) 8.1 7.4 NS 0.937 0.60–1.47
Ventilator dependence (%) 8.0 11.2 .07 1.451 0.98–2.16
Atrial fibrillation (%) 24.6 20.5 NS 0.831 0.63–1.10
Atrial flutter (%) 6.0 7.6 NS 1.174 0.75–1.84
Ventricular fibrillation (%) 6.2 6.1 NS 0.947 0.59–1.51
Ventricular tachycardia (%) 8.1 10.8 NS 1.392 0.94–2.06
Low cardiac output syndrome (%) 18.6 24.5 .004 1.526 1.15–2.03
Stroke (%) 4.4 3.0 NS 0.692 0.36–1.32
Cardiac arrest (%) 9.7 10.3 NS 1.058 0.72–1.55
Myocardial infarction (%) 3.4 5.9 .03 1.815 1.07–3.07
Mediastinal re-exploration (%) 7.8 6.5 NS 0.824 0.53–1.29
Postoperative IABP (%) 7.9 8.9 NS 1.178 0.78–1.79
Sternal wound infection (%) 0.8 2.3 .06 2.296 0.98–6.87
Leg wound infection (%) 2.9 4.0 NS 1.588 0.86–2.95
Sepsis 2.6 4.0 NS 1.473 0.77–1.49
Hospital stay (d) 13.2  13.0 14.9  13.7 .04
CABG, Coronary artery bypass grafting; BMI, body mass index; OR, odds ratio; CI, confidence interval; NS, not significant; IABP, intra-aortic balloon pump.gery c October 2009
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ative renal insufficiency, controlling for patient demographics, perioperative risk factors, and medications. Significant independent predictors of adverse
postoperative outcomes, along with their associated odds ratios and 95% confidence intervals (CI), are shown.analyses, propensity score–matched cohort analyses showed
that obesity was independently associated only with in-
creased incidence of sternal infection (P< .05) and leg
wound infection (P<.01) in patients with normal preopera-
tive renal function. Nonetheless, multivariate stepwise logis-
tic regression with or without propensity score matching
demonstrated that obesity in patients with preoperative renal
insufficiency was an independent predictor of an increased
risk of postoperative cardiovascular morbidity after CABG
surgery, although not in obese patients without preoperative
renal insufficiency.
DISCUSSION
Although obesity is recognized as a major risk factor for
cardiovascular disease, it is not clear whether obesity
increases the risk of perioperative morbidity and mortality
in patients undergoing CABG surgery. Multiple clinical
studies have investigated whether obesity is an independent
predictor of postoperative cardiovascular morbidity and
mortality after CABG surgery. However, many clinical stud-
ies have failed to demonstrate that obesity is independently
associated with an increased risk of postoperative morbidity,
including death, MI, stroke, and renal failure.23,24,26 Our
previous study suggested that although obesity was associ-
ated with minimal perioperative risk in nondiabetic patients
undergoing CABG surgery, it was a significant independent
predictor of worsened postoperative outcomes in diabetic
patients.25 We now demonstrate that obesity in patients
with normal preoperative renal function undergoing primary
CABG surgery is not independently associated with an in-
creased risk of postoperative death, MI, arrhythmias, stroke,
or prolonged hospital stay. However, obese patients withThe Journal of Thoracic and Cpreoperative renal insufficiency are almost twice as likely
to have a postoperative MI (5.9% vs 3.4%, P< .05) than
nonobese patients with preoperative renal insufficiency.
Obese patients with preoperative renal insufficiency are
also more likely to have postoperative low cardiac output
syndrome (24.5% vs 18.6%, P< .01) and to have length-
ened hospital stays (14.9  13.7 vs 13.2  13.0 days, P<
.05) compared with nonobese patients with preoperative
renal insufficiency. In addition, there was a strong trend
toward ventilator dependence (11.2% vs 8.0%, P ¼ .065)
and sternal wound infection (2.3% vs 0.8%, P ¼ .06) in
obese patients with renal insufficiency. Together, these
data strongly suggest that obesity in conjunction with renal
insufficiency confers an increased risk of worsened postop-
erative outcomes in patients undergoing primary CABG
surgery.
Common to both obesity and renal insufficiency is an
underlying systemic chronic inflammatory state. Multiple
studies have shown increased levels of inflammatory markers
in patients with obesity, the metabolic syndrome, or
both.1,8,9,12,13 Notably, there is strong evidence supporting
a role for increased markers of inflammation and increased
rates of atherosclerosis and coronary events.8,9,13,28-30 Similar
to the obesity literature, there are several studies that report
increased levels of inflammatory cytokines in patients with
renal insufficiency.31-36 Systemic inflammation in patients
with renal insufficiency is also associated with activated
markers of coagulation, which might increase the risk of
thrombotic events.35 Increasing evidence suggests that in-
creased inflammation contributes to worsened postoperative
outcomes in patients undergoing CPB.20 Therefore patients
with both obesity and renal insufficiency might also be atardiovascular Surgery c Volume 138, Number 4 877
Acquired Cardiovascular Disease Tolpin et al
A
C
Dgreater risk of adverse postoperative outcomes after CABG
surgery with CPB. Supporting this hypothesis is our observa-
tion that obesity in the presence of preoperative renal insuffi-
ciencywas independently predictive of increased incidence of
postoperative MI and low cardiac output syndrome and pro-
longed hospital stay after CABG surgery. Moreover, obesity
was not independently associated with increased risk of car-
diovascular morbidity or prolonged hospital stay in the ab-
sence of preoperative renal insufficiency.
Previous studies examining the effect of obesity on
adverse postoperative outcomes after cardiac surgery have
yielded conflicting results. Although several studies have
suggested that obesity is associated with an increased risk
of postoperative mortality,37-39 respiratory failure,25,40 and
atrial arrhythmias,25,27,40 other investigations have failed to
confirm these findings.23,24,26 However, none of these previ-
ous studies specifically investigated the effect of obesity in
patients with preoperative renal insufficiency versus patients
without preoperative renal insufficiency. In our cohort, obe-
sity was independently associated only with increased risk of
postoperative sternal and leg wound infection in patients
with normal preoperative renal function. In contrast, obesity
was independently associated with an increased risk of post-
operative MI and prolonged hospital stay in patients with
preoperative renal insufficiency. Consistent with our previ-
ous study, obesity is not independently associated with post-
operative mortality in patients undergoing CABG surgery.
Recently, Wagner and coworkers39 reported that BMI was
independently predictive of operative mortality and morbid-
ity, with a U-shape relationship. Both very low and very high
BMI affected both mortality and morbidity after CABG sur-
gery. Interestingly, this predictive U-shape relationship for
both mortality andmorbidity was flattened out in the absence
of insulin-controlled diabetes, indicating that some of the
risk associated with high BMI is attributable to the increased
incidence of diabetes. Our previous study also suggested that
obesity poses minimal perioperative risk in nondiabetic pa-
tients undergoing CABG surgery, whereas obesity in dia-
betic patients is an independent predictor of worsened
postoperative outcomes.25 Nevertheless, obesity alonemight
be a weak independent predictor of cardiovascular mortality
or morbidity after CABG surgery. However, in the context of
renal insufficiency or diabetes, obesity can then become a sig-
nificant independent predictor of postoperative outcomes
after CABG surgery.
Although this retrospective cohort study extends the re-
sults of previous studies by suggesting that obesity in the
setting of renal insufficiency is an independent risk factor
for postoperative morbidity after CABG surgery, the present
study is not without limitations.
First, patient enrollment in our study was neither prospec-
tive nor randomized. Despite the use of logistic regression
models and propensity score matching to adjust for potential878 The Journal of Thoracic and Cardiovascular Suconfounders that might affect postoperative outcomes, im-
measurable or unknown factors might still exist.
Second, data of ‘‘preoperative renal insufficiency’’ were
entered into the database by data abstractors based on criteria
of either preoperative diagnosis of renal insufficiency or fail-
ure made by clinicians or a serum creatinine level of at least
2.0 mg/dL at the time of the operation. We are unable to
quantify the severity of renal insufficiency or separate pa-
tients with dialysis-dependent renal failure from those with
renal insufficiency without dialysis-dependent renal failure.
Third, the relatively low number of patients with renal in-
sufficiency in our case series might have limited our ability
to detect independent and significant associations between
obesity and low-frequency adverse outcomes. Indeed, there
was a strong trend toward ventilator dependence (11.2% vs
8.0%, P ¼ .065) and sternal wound infection (2.3% vs
0.8%, P ¼ .06) in obese patients with renal insufficiency.
However, the difference did not reach statistical signifi-
cance. Further research with appropriately designed pro-
spective trials is thus necessary to evaluate the effect of
obesity on surgical outcomes in these subpopulations.
Data obtained from such studies might improve periopera-
tive risk stratification and resource use.
In conclusion, obesity appears to confer a greater risk of
postoperative cardiovascular morbidity, but not mortality,
after primary CABG surgery in patients with preoperative
renal insufficiency.
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